Research Paper Volume 15, Issue 13 pp 6179—6211
ZNF765 is a prognostic biomarker of hepatocellular carcinoma associated with cell cycle, immune infiltration, m6A modification, and drug susceptibility
Figure 4. The effectiveness of ZNF765 in predicting prognosis. (A) HCC patients with a lower expression level of ZNF765 had favorable a prognosis (p = 0.024). (B) ROC curves for the 1-, 3-, and 5-year survival according to the expression level of ZNF765. Abbreviation: AUC: the area under the curve; ROC: receiver operating characteristic. (C) A forest plot of the results of the multivariate analysis. *p < 0.05; **p < 0.01; ***p < 0.001. Abbreviations: HR: hazard ratio; CI: confidence interval; T: tumor; N: node, M: metastasis; OS: overall survival; AIC: Akaike’s information criterion.